 NASHVILLE, Tenn., June 22, 2021 PRNewswire -- Cryoport, Inc. NASDAQ: CYRX Cryoport or the Company, a global leader in temperature-controlled supply chain solutions for the life sciences industry, today announced that Cellenkos , Inc., a privately held, clinical-stage biotechnology company, has selected Cryoport to provide a staged, on-demand, logistics solution for COVID-19 therapy shipments for patients in need. 